Home / Market News / $ALEC

$ALEC news and market catalysts

The 6 most recent market catalysts affecting $ALEC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

6 catalysts 2 high impact 4 bullish 0 bearish Biotechnology
Nov 13, 2026 Corporate Catalyst Neutral Impact 65
Wells Fargo Initiates Coverage of Alector with Overweight Rating
Wells Fargo Securities has initiated coverage on Alector, Inc. with an 'Overweight' rating and a $7 price target, effective November 13, 2026. This analyst initiation is a positive…
Nov 6, 2026 Corporate Catalyst Bullish Impact 92
Alector Reports Third Quarter 2026 Financial Results
Alector reported a substantial turnaround in Q3 2026, moving from a net loss to significant net income and revenue. This was primarily due to the recognition of deferred revenue fo…
Oct 16, 2026 Corporate Catalyst Neutral Impact 75
Alector Prices $75.03M Common Stock Offering Of 36.6M Shares At $2.05/Share
This headline indicates a significant common stock offering by Alector, which will dilute existing shareholders. The offering price of $2.05 per share is likely below the current m…
Oct 15, 2026 Corporate Catalyst Bullish Impact 55
HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $8
HC Wainwright & Co. analyst Andrew S. Fein maintained a 'Buy' rating on Alector (ALEC) and raised the price target from $5 to $8. This action signals increased confidence from the …
Oct 14, 2026 Corporate Catalyst Bullish Impact 55
HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $8
HC Wainwright & Co. analyst Andrew S. Fein maintained a 'Buy' rating on Alector (ALEC) and raised the price target from $5 to $8. This indicates a strengthened conviction from the …
Oct 5, 2026 Corporate Catalyst Bullish Impact 85
Alector shares are trading higher after the company announced an exclusive global licensing agreement granting Genentech worldwide rights to develop and commercialize its AL050 program.
This licensing agreement is a significant positive catalyst for Alector, as it provides substantial upfront payments, potential milestone payments, and royalties, significantly bol…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.